Loading…
Cencora, Inc. is projected to rise to $366.34 by 2027, a +21% move from its current price of $303.44. COR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $299.61 | $303.56 | $307.56 | +0.04% |
| Jul 15 | $298.11 | $303.68 | $309.35 | +0.08% |
| Jul 16 | $296.98 | $303.80 | $310.76 | +0.12% |
| Jul 17 | $296.06 | $303.92 | $311.98 | +0.16% |
| Jul 18 | $295.26 | $304.03 | $313.07 | +0.20% |
| Jul 19 | $294.55 | $304.15 | $314.07 | +0.23% |
| Jul 20 | $293.91 | $304.27 | $315.00 | +0.27% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $293.91 | $304.27 | $315.00 | +0.27% |
| Week 2 | $290.52 | $305.11 | $320.43 | +0.55% |
| Week 3 | $288.13 | $305.94 | $324.86 | +0.82% |
| Week 4 | $286.25 | $306.78 | $328.79 | +1.10% |
| Week 5 | $284.69 | $307.62 | $332.40 | +1.38% |
| Week 6 | $283.37 | $308.47 | $335.78 | +1.66% |
| Week 7 | $282.22 | $309.31 | $339.00 | +1.93% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cencora, Inc. (COR) is a healthcare company focused on sourcing and distributing pharmaceutical products in the United States and internationally. Its operations cover a wide range of services and products, including generic and injectable pharmaceuticals, over-the-counter healthcare items, home healthcare supplies and equipment, vaccines, plasma and other blood products, and related services for hospitals, health systems, and various pharmacy channels.
The company also provides pharmacy management, supply management software, packaging, data analytics, and other support services to manufacturers and healthcare providers, as well as services to animal health markets. The business is organized around two segments: U.S. Healthcare Solutions and International Healthcare Solutions.
Cencora was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. It was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Cencora, Inc. trades as COR with a current price of $296.51 and a market capitalization of $57.69B, and it holds a ranking position of 273. The stock carries a near-term forecast showing a neutral stance for 2026, with an expected average price of $296.51 and a price range of $252.74 to $402.21.
Looking further out, the outlook turns bullish from 2027 through 2050, with rising average prices and increasing ROI estimates, culminating in substantial long-term upside by 2050.
A major floor 18.8% below — a decisive break under it would weaken the trend.
The nearest floor, 13.1% below — buyers have tended to step in here.
Price is pressing into resistance (2.0% away) — a breakout level to watch.
A major ceiling 22.4% above — clearing it would confirm fresh momentum.
Key COR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of COR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $303.70 | Sell | $301.96 | Buy |
| MA 10 | $295.42 | Buy | $297.04 | Buy |
| MA 20 | $287.65 | Buy | $290.39 | Buy |
| MA 50 | $278.64 | Buy | $289.34 | Buy |
| MA 100 | $307.38 | Sell | $300.24 | Buy |
| MA 200 | $324.64 | Sell | $307.13 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 65.25 | Neutral |
| Stoch RSI (14) | 72.30 | Neutral |
| CCI (20) | 117.11 | Buy |
| Williams %R (14) | -16.01 | Info |
| MACD (12,26,9) | 2.50 | Buy |
| ROC (12) | 7.95 | Buy |
| Bollinger %B (20,2) | 0.87 | Neutral |
| Stochastic %K (14) | 83.99 | Sell |
| TRIX (15) | 0.25 | Buy |
| Awesome (5,34) | 23.07 | Buy |
| Ultimate (7,14,28) | 77.31 | Sell |
| Momentum (10) | 16.49 | Buy |
| Aroon Osc (25) | 92.00 | Buy |
| Hull MA (9) | 309.47 | Sell |
| ADX (14) | 22.87 | Buy |
| ATR (14) | 3.84 | Info |
The 30-day technical picture shows bullish sentiment with RSI(14) at 70, a 50-day simple moving average of $279.27 and a 200-day simple moving average of $324.29. The price sits above a support level at $263.64 and below a resistance level at $296.51. Over the past 30 days, the trading range has been from a low of $271.93 to a high of $323.31, indicating a constructive but potentially choppy near-term dynamic as the stock tests the $296.51 area.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $252.74 | $303.44 | $406.33 | 0% | Neutral | |
| $300.04 | $366.34 | $467.64 | +21% | Bullish | |
| $317.73 | $395.22 | $518.16 | +30% | Bullish | |
| $336.50 | $425.04 | $569.12 | +40% | Bullish | |
| $364.26 | $466.31 | $635.63 | +54% | Bullish | |
| $417.41 | $540.89 | $748.94 | +78% | Bullish | |
| $475.03 | $622.50 | $874.21 | +105% | Bullish | |
| $531.78 | $704.21 | $1,001.76 | +132% | Bullish | |
| $568.42 | $760.22 | $1,094.37 | +151% | Bullish | |
| $584.15 | $788.66 | $1,147.94 | +160% | Bullish | |
| $866.40 | $1,220.01 | $1,860.95 | +302% | Bullish | |
| $1,483.74 | $2,240.77 | $3,663.83 | +638% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $252.74 | $303.44 | $356.34 | +0.00% |
| August 2026 | $259.71 | $303.98 | $363.50 | +0.18% |
| September 2026 | $267.37 | $314.46 | $378.97 | +3.45% |
| October 2026 | $270.47 | $319.42 | $387.49 | +1.58% |
| November 2026 | $270.65 | $320.74 | $391.25 | +0.41% |
| December 2026 | $278.76 | $331.42 | $406.33 | +3.33% |
Click any year to see its month-by-month COR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Cencora, Inc.'s 2026 outlook centres on $303.44, within a $252.74 to $406.33 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, COR could reach as high as $467.64, with a base case around $366.34 and support toward $300.04 — roughly +21% from $303.44. Momentum favours further upside here.
Expect COR to range from $317.73 to $518.16 through 2028. The $395.22 average target implies a +30% move from current prices. That is up +8% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The COR price prediction for 2029 points to an average of $425.04 (low $336.50, high $569.12) — a potential gain of +40% on today's $303.44. Momentum favours further upside here.
In 2030, COR is projected to trade between $364.26 and $635.63, averaging $466.31 — a potential gain of +54% from today's $303.44. That is up +10% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Cencora, Inc.'s 2031 outlook centres on $540.89, within a $417.41 to $748.94 range. That is up +16% on the projected 2030 average. That marks a +78% change versus current levels. Momentum favours further upside here.
By 2032, COR could reach as high as $874.21, with a base case around $622.50 and support toward $475.03 — roughly +105% from $303.44. Buyers look set to stay in control over this stretch.
Expect COR to range from $531.78 to $1,001.76 through 2033. The $704.21 average target implies a +132% move from current prices. That is up +13% on the projected 2032 average. Momentum favours further upside here.
The COR price prediction for 2034 points to an average of $760.22 (low $568.42, high $1,094.37) — a potential gain of +151% on today's $303.44. Buyers look set to stay in control over this stretch.
In 2035, COR is projected to trade between $584.15 and $1,147.94, averaging $788.66 — a potential gain of +160% from today's $303.44. That is up +4% on the projected 2034 average. Momentum favours further upside here.
Cencora, Inc.'s 2040 outlook centres on $1,220.01, within a $866.40 to $1,860.95 range. That is up +55% on the projected 2035 average. That marks a +302% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, COR could reach as high as $3,663.83, with a base case around $2,240.77 and support toward $1,483.74 — roughly +638% from $303.44. Momentum favours further upside here.
Investing $1,000 in COR today (≈ 3.295544 COR) could be worth
$7,384.57
+$6,384.57 (+638%) by 2050 · US Dollar
Based on the average projected COR price of $2,240.77 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CORwould be worth at today's price.
$1,000 invested in COR on Jul 10, 2025 (≈ 3.363379 COR) would be worth
$1,020.58
+$20.58 (+2.1%) today · 1.02× · US Dollar
Based on a COR entry price of $297.32 vs. today's $303.44.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $296.51 | $1,023.37 | +2.3% |
| 1 month ago | $281.24 | $1,078.94 | +7.9% |
| 3 months ago | $320.82 | $945.83 | -5.4% |
| 6 months ago | $342.16 | $886.84 | -11.3% |
| 1 year ago | $297.32 | $1,020.58 | +2.1% |
| All time (5.0y) ago | $113.56 | $2,672.07 | +167.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our COR forecast.
Our base-case forecast reaches $610.00 around 2032.
Implied market cap at $610.00: $118.68B
The multi-year forecast depicts a gradual move higher, with 2026 showing an average price of $296.51 and a neutral sentiment. Beyond 2026, the outlook becomes steadily bullish: 2027 average $356.39, 2028 average $383.08, 2029 average $417.66, and 2030 average $451.84 with a 52.4 ROI and a bullish sentiment. For the longer horizon, 2040 data point shows an average of $1,173.17 and a 295.7 ROI, with a max forecast of $1,789.86, and 2050 projects an average of $2,171.03 with a 632.2 ROI and a max of $3,550.33.
These figures imply meaningful long-term upside, tempered by the inherent uncertainty of investing and the fact that forecasts are not guarantees.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $451.84, with a min of $352.84 and a max of $616.15. The ROI figure attached to 2030 is 52.4, and the sentiment is BULLISH.
The outlook from 2027 onward is BULLISH with rising averages and ROI through 2050 (e.g., 2027 avg $356.39, 2040 avg $1,173.17, 2050 avg $2,171.03). The 2026 forecast is NEUTRAL, and these are estimates, not guarantees.
Yes. The 2030 max forecast is $616.15, with a 2030 min of $352.84 and an average of $451.84, and an attached ROI of 52.4.
For 2040, the forecast provides a min of $832.97, an average of $1,173.17, and a max of $1,789.86, with a ROI of 295.7 and a BULLISH sentiment.
For 2050, the forecast provides a min of $1,437.33, an average of $2,171.03, and a max of $3,550.33, with a ROI of 632.2 and a BULLISH sentiment.
Cencora, Inc. Community Discussion
0Share your Cencora, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.